BACKGROUND: Little is known about the effects of alcohol dependence on cortical concentrations of glutamate (Glu) or gamma aminobutyric acid (GABA). We used proton magnetic resonance spectroscopy (MRS) to study cross-sectionally and longitudinally the concentrations of these in alcohol dependent individuals (ALC) during early abstinence from alcohol. METHODS: Twenty ALC were studied at about one week of abstinence from alcohol (baseline) and 36 ALC at five weeks of abstinence and compared to 16 light/non-drinking controls (LD). Eleven ALC were studied twice during abstinence. Participants underwent clinical interviewing, blood work, neuropsychological testing, structural imaging and single-volume proton MRS at 4Tesla. Absolute concentrations of Glu, GABA and those of other (1)H MRS-detectable metabolites were measured in the anterior cingulate (ACC), parieto-occipital cortex (POC) and dorso-lateral prefrontal cortex (DLPFC). Relationships of metabolite levels to drinking severity and neurocognition were also assessed. RESULTS: ALC at baseline had lower concentrations of Glu, N-acetylaspartate (NAA), choline- (Cho) and creatine-containing metabolites (Cr) than LD in the ACC, but had normal GABA and myo-inositol (mI) levels. At five weeks of abstinence, metabolite concentrations were not significantly different between groups. Between one and five weeks of abstinence, Glu, NAA and Cho levels in the ACC increased significantly. Higher cortical mI concentrations in ALC related to worse neurocognitive outcome. CONCLUSION: These MRS data suggest compromised and regionally specific bioenergetics/metabolism in one-week-abstinent ALC that largely normalizes over four weeks of sustained abstinence. The correlation between mI levels and neurocognition affirms the functional relevance of this putative astrocyte marker. Published by Elsevier Ireland Ltd.
BACKGROUND: Little is known about the effects of alcohol dependence on cortical concentrations of glutamate (Glu) or gamma aminobutyric acid (GABA). We used proton magnetic resonance spectroscopy (MRS) to study cross-sectionally and longitudinally the concentrations of these in alcohol dependent individuals (ALC) during early abstinence from alcohol. METHODS: Twenty ALC were studied at about one week of abstinence from alcohol (baseline) and 36 ALC at five weeks of abstinence and compared to 16 light/non-drinking controls (LD). Eleven ALC were studied twice during abstinence. Participants underwent clinical interviewing, blood work, neuropsychological testing, structural imaging and single-volume proton MRS at 4Tesla. Absolute concentrations of Glu, GABA and those of other (1)H MRS-detectable metabolites were measured in the anterior cingulate (ACC), parieto-occipital cortex (POC) and dorso-lateral prefrontal cortex (DLPFC). Relationships of metabolite levels to drinking severity and neurocognition were also assessed. RESULTS:ALC at baseline had lower concentrations of Glu, N-acetylaspartate (NAA), choline- (Cho) and creatine-containing metabolites (Cr) than LD in the ACC, but had normal GABA and myo-inositol (mI) levels. At five weeks of abstinence, metabolite concentrations were not significantly different between groups. Between one and five weeks of abstinence, Glu, NAA and Cho levels in the ACC increased significantly. Higher cortical mI concentrations in ALC related to worse neurocognitive outcome. CONCLUSION: These MRS data suggest compromised and regionally specific bioenergetics/metabolism in one-week-abstinent ALC that largely normalizes over four weeks of sustained abstinence. The correlation between mI levels and neurocognition affirms the functional relevance of this putative astrocyte marker. Published by Elsevier Ireland Ltd.
Authors: George Bush; Brent A Vogt; Jennifer Holmes; Anders M Dale; Douglas Greve; Michael A Jenike; Bruce R Rosen Journal: Proc Natl Acad Sci U S A Date: 2001-12-26 Impact factor: 11.205
Authors: Andreas J Bartsch; György Homola; Armin Biller; Stephen M Smith; Heinz-Gerd Weijers; Gerhard A Wiesbeck; Mark Jenkinson; Nicola De Stefano; László Solymosi; Martin Bendszus Journal: Brain Date: 2007-01 Impact factor: 13.501
Authors: Gabriele Ende; Helga Welzel; Sigi Walter; Wolfgang Weber-Fahr; Alexander Diehl; Derik Hermann; Andreas Heinz; Karl Mann Journal: Biol Psychiatry Date: 2005-08-08 Impact factor: 13.382
Authors: B C Schweinsburg; M J Taylor; O M Alhassoon; J S Videen; G G Brown; T L Patterson; F Berger; I Grant Journal: Alcohol Clin Exp Res Date: 2001-06 Impact factor: 3.455
Authors: James J Prisciandaro; Joseph P Schacht; Andrew P Prescot; Perry F Renshaw; Truman R Brown; Raymond F Anton Journal: Alcohol Clin Exp Res Date: 2019-01-04 Impact factor: 3.455
Authors: Timothy C Durazzo; Dieter J Meyerhoff; Anderson Mon; Christoph Abé; Stefan Gazdzinski; Donna E Murray Journal: Biol Psychiatry Date: 2015-04-09 Impact factor: 13.382
Authors: Ansel T Hillmer; Graeme F Mason; Lisa M Fucito; Stephanie S O'Malley; Kelly P Cosgrove Journal: Alcohol Clin Exp Res Date: 2015-10-28 Impact factor: 3.455
Authors: James J Prisciandaro; Joseph P Schacht; Andrew P Prescot; Helena M Brenner; Perry F Renshaw; Truman R Brown; Raymond F Anton Journal: Addict Biol Date: 2019-08-01 Impact factor: 4.280
Authors: Marisa M Silveri; Jennifer T Sneider; David J Crowley; Michael J Covell; Deepa Acharya; Isabelle M Rosso; J Eric Jensen Journal: Biol Psychiatry Date: 2013-03-14 Impact factor: 13.382